Global Fish Vaccine
Global Fish Vaccine

Fish Vaccine Comprehensive Study by Type (Live, Inactivated, Subunit, DNA, Others), Administration (Oral, Immersion, Injected), Fish (Salmon, Trout, Sea Bass, Others) Players and Region - Global Market Outlook to 2026

Fish Vaccine Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Aug 2021 Edition 206 Pages 211 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Fish Vaccine Market Scope
Immunization of fish is often used for many years and is widely recognised as an efficient technique of preventing a variety of bacterial and viral infections. Vaccination initiatives contribute to global aquaculture's environmental, social, and economic sustainability. Traditionally, most licensed fish vaccines were inactivated microorganisms prepared with adjuvants and administered via immersion or injection. Subunit or recombinant DNA/RNA particle vaccines are examples of vaccinations made using modern vaccine technologies that target individual pathogen components. These cutting-edge technologies have been developed all around the world, and they appear to produce higher levels of immunity than traditional fish vaccines. Advanced technologies have showed significant promise for the future of aquaculture vaccines, and will give producers with health benefits as well as increased commercial potential.

The Fish Vaccine market study is segmented by Type (Live, Inactivated, Subunit, DNA and Others) and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Fish Vaccine market throughout the predicted period.

AquaTactics Fish Health (United States), Hipra (India), Ictyogroup (France), Intervet International B.V. (Netherlands), Microsynbiotix (Ireland), Nisseiken Co., Ltd. (Japan), Pfizer Inc. (United States), Kyoritsuseiyaku Corporation (Japan) and Tecnovax S.A. (Argentina) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Veterquimica SA (Chile), Zoetis Inc. (United States), Merck KGaA (Germany) and Seppic (France).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
AMA Research has segmented the market of Global Fish Vaccine market by Type, Application and Region.

On the basis of geography, the market of Fish Vaccine has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Leaders and their expansionary development strategies
On 6th December, 2018 - Aquaculture Acquired Assets of KoVax Ltd. (Israel based Vaccine Manufacturer). Phibro's Position in Fish Vaccine Discovery Is Strengthened, And Its Aquaculture Product Line Is Expanded. The R&D Team from KoVax Joined Phibro's Biological Segment, With the Goal of Developing a Pipeline of Novel Vaccines for The Aquaculture. and On 25th January, 2017 Pharmaq (Zoetis Unit) Acquired Norwegian Fish Vaccination Company. Pharmaq Will Be Able to Provide Complete Vaccination Solutions to Customers All Over the World as A Result of Its Takeover of Nordland Sett Vaks.
On 30th April, 2021 - CIBA Launched India's First Homegrown Fish Vaccine for Viral Nervous Necrosis (VNN). CIBA-Nodavac-R is an Injectable Recombinant VNN Vaccine That Efficiently Protects Fingerlings from VNN Produced by Red-Spotted Grouper Nervous Necrosis Virus (RGNNV) And Prevents Vertical Transmission in Brooders.


Market Trend
  • Emergence of Advance Fish Vaccine Techniques

Market Drivers
  • Prevalence of Infectious Diseases
  • Growing Aquaculture Industry

Opportunities
  • Increasing Number of Artificial Fisheries Across Emerging Regions

Restraints
  • Stringent Environmental Regulations

Challenges
  • Fierce Competitive Pressure
  • High Initial Investment


Key Target Audience
Fish Vaccine Manufactures, New Entrants and Investors, Fish Vaccine Distributors and Suppliers, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

Frequently Asked Questions (FAQ):

1. Is it possible to have certain customization in the study?
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a study that suits your business objectives.

2. How big is the Fish Vaccine Market?
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2026.

Report Objectives / Segmentation Covered
By Type
  • Live
  • Inactivated
  • Subunit
  • DNA
  • Others
By Administration
  • Oral
  • Immersion
  • Injected

By Fish
  • Salmon
  • Trout
  • Sea Bass
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Prevalence of Infectious Diseases
      • 3.2.2. Growing Aquaculture Industry
    • 3.3. Market Challenges
      • 3.3.1. Fierce Competitive Pressure
      • 3.3.2. High Initial Investment
    • 3.4. Market Trends
      • 3.4.1. Emergence of Advance Fish Vaccine Techniques
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Fish Vaccine, by Type, Administration, Fish and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Fish Vaccine (Value)
      • 5.2.1. Global Fish Vaccine by: Type (Value)
        • 5.2.1.1. Live
        • 5.2.1.2. Inactivated
        • 5.2.1.3. Subunit
        • 5.2.1.4. DNA
        • 5.2.1.5. Others
      • 5.2.2. Global Fish Vaccine by: Administration (Value)
        • 5.2.2.1. Oral
        • 5.2.2.2. Immersion
        • 5.2.2.3. Injected
      • 5.2.3. Global Fish Vaccine by: Fish (Value)
        • 5.2.3.1. Salmon
        • 5.2.3.2. Trout
        • 5.2.3.3. Sea Bass
        • 5.2.3.4. Others
      • 5.2.4. Global Fish Vaccine Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Fish Vaccine: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. AquaTactics Fish Health (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Hipra (India)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Ictyogroup (France)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Intervet International B.V. (Netherlands)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Microsynbiotix (Ireland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Nisseiken Co., Ltd. (Japan)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Pfizer Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Kyoritsuseiyaku Corporation (Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Tecnovax S.A. (Argentina)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Fish Vaccine Sale, by Type, Administration, Fish and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Fish Vaccine (Value)
      • 7.2.1. Global Fish Vaccine by: Type (Value)
        • 7.2.1.1. Live
        • 7.2.1.2. Inactivated
        • 7.2.1.3. Subunit
        • 7.2.1.4. DNA
        • 7.2.1.5. Others
      • 7.2.2. Global Fish Vaccine by: Administration (Value)
        • 7.2.2.1. Oral
        • 7.2.2.2. Immersion
        • 7.2.2.3. Injected
      • 7.2.3. Global Fish Vaccine by: Fish (Value)
        • 7.2.3.1. Salmon
        • 7.2.3.2. Trout
        • 7.2.3.3. Sea Bass
        • 7.2.3.4. Others
      • 7.2.4. Global Fish Vaccine Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Fish Vaccine: by Type(USD Million)
  • Table 2. Fish Vaccine Live , by Region USD Million (2015-2020)
  • Table 3. Fish Vaccine Inactivated , by Region USD Million (2015-2020)
  • Table 4. Fish Vaccine Subunit , by Region USD Million (2015-2020)
  • Table 5. Fish Vaccine DNA , by Region USD Million (2015-2020)
  • Table 6. Fish Vaccine Others , by Region USD Million (2015-2020)
  • Table 7. Fish Vaccine: by Administration(USD Million)
  • Table 8. Fish Vaccine Oral , by Region USD Million (2015-2020)
  • Table 9. Fish Vaccine Immersion , by Region USD Million (2015-2020)
  • Table 10. Fish Vaccine Injected , by Region USD Million (2015-2020)
  • Table 11. Fish Vaccine: by Fish(USD Million)
  • Table 12. Fish Vaccine Salmon , by Region USD Million (2015-2020)
  • Table 13. Fish Vaccine Trout , by Region USD Million (2015-2020)
  • Table 14. Fish Vaccine Sea Bass , by Region USD Million (2015-2020)
  • Table 15. Fish Vaccine Others , by Region USD Million (2015-2020)
  • Table 16. South America Fish Vaccine, by Country USD Million (2015-2020)
  • Table 17. South America Fish Vaccine, by Type USD Million (2015-2020)
  • Table 18. South America Fish Vaccine, by Administration USD Million (2015-2020)
  • Table 19. South America Fish Vaccine, by Fish USD Million (2015-2020)
  • Table 20. Brazil Fish Vaccine, by Type USD Million (2015-2020)
  • Table 21. Brazil Fish Vaccine, by Administration USD Million (2015-2020)
  • Table 22. Brazil Fish Vaccine, by Fish USD Million (2015-2020)
  • Table 23. Argentina Fish Vaccine, by Type USD Million (2015-2020)
  • Table 24. Argentina Fish Vaccine, by Administration USD Million (2015-2020)
  • Table 25. Argentina Fish Vaccine, by Fish USD Million (2015-2020)
  • Table 26. Rest of South America Fish Vaccine, by Type USD Million (2015-2020)
  • Table 27. Rest of South America Fish Vaccine, by Administration USD Million (2015-2020)
  • Table 28. Rest of South America Fish Vaccine, by Fish USD Million (2015-2020)
  • Table 29. Asia Pacific Fish Vaccine, by Country USD Million (2015-2020)
  • Table 30. Asia Pacific Fish Vaccine, by Type USD Million (2015-2020)
  • Table 31. Asia Pacific Fish Vaccine, by Administration USD Million (2015-2020)
  • Table 32. Asia Pacific Fish Vaccine, by Fish USD Million (2015-2020)
  • Table 33. China Fish Vaccine, by Type USD Million (2015-2020)
  • Table 34. China Fish Vaccine, by Administration USD Million (2015-2020)
  • Table 35. China Fish Vaccine, by Fish USD Million (2015-2020)
  • Table 36. Japan Fish Vaccine, by Type USD Million (2015-2020)
  • Table 37. Japan Fish Vaccine, by Administration USD Million (2015-2020)
  • Table 38. Japan Fish Vaccine, by Fish USD Million (2015-2020)
  • Table 39. India Fish Vaccine, by Type USD Million (2015-2020)
  • Table 40. India Fish Vaccine, by Administration USD Million (2015-2020)
  • Table 41. India Fish Vaccine, by Fish USD Million (2015-2020)
  • Table 42. South Korea Fish Vaccine, by Type USD Million (2015-2020)
  • Table 43. South Korea Fish Vaccine, by Administration USD Million (2015-2020)
  • Table 44. South Korea Fish Vaccine, by Fish USD Million (2015-2020)
  • Table 45. Taiwan Fish Vaccine, by Type USD Million (2015-2020)
  • Table 46. Taiwan Fish Vaccine, by Administration USD Million (2015-2020)
  • Table 47. Taiwan Fish Vaccine, by Fish USD Million (2015-2020)
  • Table 48. Australia Fish Vaccine, by Type USD Million (2015-2020)
  • Table 49. Australia Fish Vaccine, by Administration USD Million (2015-2020)
  • Table 50. Australia Fish Vaccine, by Fish USD Million (2015-2020)
  • Table 51. Rest of Asia-Pacific Fish Vaccine, by Type USD Million (2015-2020)
  • Table 52. Rest of Asia-Pacific Fish Vaccine, by Administration USD Million (2015-2020)
  • Table 53. Rest of Asia-Pacific Fish Vaccine, by Fish USD Million (2015-2020)
  • Table 54. Europe Fish Vaccine, by Country USD Million (2015-2020)
  • Table 55. Europe Fish Vaccine, by Type USD Million (2015-2020)
  • Table 56. Europe Fish Vaccine, by Administration USD Million (2015-2020)
  • Table 57. Europe Fish Vaccine, by Fish USD Million (2015-2020)
  • Table 58. Germany Fish Vaccine, by Type USD Million (2015-2020)
  • Table 59. Germany Fish Vaccine, by Administration USD Million (2015-2020)
  • Table 60. Germany Fish Vaccine, by Fish USD Million (2015-2020)
  • Table 61. France Fish Vaccine, by Type USD Million (2015-2020)
  • Table 62. France Fish Vaccine, by Administration USD Million (2015-2020)
  • Table 63. France Fish Vaccine, by Fish USD Million (2015-2020)
  • Table 64. Italy Fish Vaccine, by Type USD Million (2015-2020)
  • Table 65. Italy Fish Vaccine, by Administration USD Million (2015-2020)
  • Table 66. Italy Fish Vaccine, by Fish USD Million (2015-2020)
  • Table 67. United Kingdom Fish Vaccine, by Type USD Million (2015-2020)
  • Table 68. United Kingdom Fish Vaccine, by Administration USD Million (2015-2020)
  • Table 69. United Kingdom Fish Vaccine, by Fish USD Million (2015-2020)
  • Table 70. Netherlands Fish Vaccine, by Type USD Million (2015-2020)
  • Table 71. Netherlands Fish Vaccine, by Administration USD Million (2015-2020)
  • Table 72. Netherlands Fish Vaccine, by Fish USD Million (2015-2020)
  • Table 73. Rest of Europe Fish Vaccine, by Type USD Million (2015-2020)
  • Table 74. Rest of Europe Fish Vaccine, by Administration USD Million (2015-2020)
  • Table 75. Rest of Europe Fish Vaccine, by Fish USD Million (2015-2020)
  • Table 76. MEA Fish Vaccine, by Country USD Million (2015-2020)
  • Table 77. MEA Fish Vaccine, by Type USD Million (2015-2020)
  • Table 78. MEA Fish Vaccine, by Administration USD Million (2015-2020)
  • Table 79. MEA Fish Vaccine, by Fish USD Million (2015-2020)
  • Table 80. Middle East Fish Vaccine, by Type USD Million (2015-2020)
  • Table 81. Middle East Fish Vaccine, by Administration USD Million (2015-2020)
  • Table 82. Middle East Fish Vaccine, by Fish USD Million (2015-2020)
  • Table 83. Africa Fish Vaccine, by Type USD Million (2015-2020)
  • Table 84. Africa Fish Vaccine, by Administration USD Million (2015-2020)
  • Table 85. Africa Fish Vaccine, by Fish USD Million (2015-2020)
  • Table 86. North America Fish Vaccine, by Country USD Million (2015-2020)
  • Table 87. North America Fish Vaccine, by Type USD Million (2015-2020)
  • Table 88. North America Fish Vaccine, by Administration USD Million (2015-2020)
  • Table 89. North America Fish Vaccine, by Fish USD Million (2015-2020)
  • Table 90. United States Fish Vaccine, by Type USD Million (2015-2020)
  • Table 91. United States Fish Vaccine, by Administration USD Million (2015-2020)
  • Table 92. United States Fish Vaccine, by Fish USD Million (2015-2020)
  • Table 93. Canada Fish Vaccine, by Type USD Million (2015-2020)
  • Table 94. Canada Fish Vaccine, by Administration USD Million (2015-2020)
  • Table 95. Canada Fish Vaccine, by Fish USD Million (2015-2020)
  • Table 96. Mexico Fish Vaccine, by Type USD Million (2015-2020)
  • Table 97. Mexico Fish Vaccine, by Administration USD Million (2015-2020)
  • Table 98. Mexico Fish Vaccine, by Fish USD Million (2015-2020)
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Fish Vaccine: by Type(USD Million)
  • Table 109. Fish Vaccine Live , by Region USD Million (2021-2026)
  • Table 110. Fish Vaccine Inactivated , by Region USD Million (2021-2026)
  • Table 111. Fish Vaccine Subunit , by Region USD Million (2021-2026)
  • Table 112. Fish Vaccine DNA , by Region USD Million (2021-2026)
  • Table 113. Fish Vaccine Others , by Region USD Million (2021-2026)
  • Table 114. Fish Vaccine: by Administration(USD Million)
  • Table 115. Fish Vaccine Oral , by Region USD Million (2021-2026)
  • Table 116. Fish Vaccine Immersion , by Region USD Million (2021-2026)
  • Table 117. Fish Vaccine Injected , by Region USD Million (2021-2026)
  • Table 118. Fish Vaccine: by Fish(USD Million)
  • Table 119. Fish Vaccine Salmon , by Region USD Million (2021-2026)
  • Table 120. Fish Vaccine Trout , by Region USD Million (2021-2026)
  • Table 121. Fish Vaccine Sea Bass , by Region USD Million (2021-2026)
  • Table 122. Fish Vaccine Others , by Region USD Million (2021-2026)
  • Table 123. South America Fish Vaccine, by Country USD Million (2021-2026)
  • Table 124. South America Fish Vaccine, by Type USD Million (2021-2026)
  • Table 125. South America Fish Vaccine, by Administration USD Million (2021-2026)
  • Table 126. South America Fish Vaccine, by Fish USD Million (2021-2026)
  • Table 127. Brazil Fish Vaccine, by Type USD Million (2021-2026)
  • Table 128. Brazil Fish Vaccine, by Administration USD Million (2021-2026)
  • Table 129. Brazil Fish Vaccine, by Fish USD Million (2021-2026)
  • Table 130. Argentina Fish Vaccine, by Type USD Million (2021-2026)
  • Table 131. Argentina Fish Vaccine, by Administration USD Million (2021-2026)
  • Table 132. Argentina Fish Vaccine, by Fish USD Million (2021-2026)
  • Table 133. Rest of South America Fish Vaccine, by Type USD Million (2021-2026)
  • Table 134. Rest of South America Fish Vaccine, by Administration USD Million (2021-2026)
  • Table 135. Rest of South America Fish Vaccine, by Fish USD Million (2021-2026)
  • Table 136. Asia Pacific Fish Vaccine, by Country USD Million (2021-2026)
  • Table 137. Asia Pacific Fish Vaccine, by Type USD Million (2021-2026)
  • Table 138. Asia Pacific Fish Vaccine, by Administration USD Million (2021-2026)
  • Table 139. Asia Pacific Fish Vaccine, by Fish USD Million (2021-2026)
  • Table 140. China Fish Vaccine, by Type USD Million (2021-2026)
  • Table 141. China Fish Vaccine, by Administration USD Million (2021-2026)
  • Table 142. China Fish Vaccine, by Fish USD Million (2021-2026)
  • Table 143. Japan Fish Vaccine, by Type USD Million (2021-2026)
  • Table 144. Japan Fish Vaccine, by Administration USD Million (2021-2026)
  • Table 145. Japan Fish Vaccine, by Fish USD Million (2021-2026)
  • Table 146. India Fish Vaccine, by Type USD Million (2021-2026)
  • Table 147. India Fish Vaccine, by Administration USD Million (2021-2026)
  • Table 148. India Fish Vaccine, by Fish USD Million (2021-2026)
  • Table 149. South Korea Fish Vaccine, by Type USD Million (2021-2026)
  • Table 150. South Korea Fish Vaccine, by Administration USD Million (2021-2026)
  • Table 151. South Korea Fish Vaccine, by Fish USD Million (2021-2026)
  • Table 152. Taiwan Fish Vaccine, by Type USD Million (2021-2026)
  • Table 153. Taiwan Fish Vaccine, by Administration USD Million (2021-2026)
  • Table 154. Taiwan Fish Vaccine, by Fish USD Million (2021-2026)
  • Table 155. Australia Fish Vaccine, by Type USD Million (2021-2026)
  • Table 156. Australia Fish Vaccine, by Administration USD Million (2021-2026)
  • Table 157. Australia Fish Vaccine, by Fish USD Million (2021-2026)
  • Table 158. Rest of Asia-Pacific Fish Vaccine, by Type USD Million (2021-2026)
  • Table 159. Rest of Asia-Pacific Fish Vaccine, by Administration USD Million (2021-2026)
  • Table 160. Rest of Asia-Pacific Fish Vaccine, by Fish USD Million (2021-2026)
  • Table 161. Europe Fish Vaccine, by Country USD Million (2021-2026)
  • Table 162. Europe Fish Vaccine, by Type USD Million (2021-2026)
  • Table 163. Europe Fish Vaccine, by Administration USD Million (2021-2026)
  • Table 164. Europe Fish Vaccine, by Fish USD Million (2021-2026)
  • Table 165. Germany Fish Vaccine, by Type USD Million (2021-2026)
  • Table 166. Germany Fish Vaccine, by Administration USD Million (2021-2026)
  • Table 167. Germany Fish Vaccine, by Fish USD Million (2021-2026)
  • Table 168. France Fish Vaccine, by Type USD Million (2021-2026)
  • Table 169. France Fish Vaccine, by Administration USD Million (2021-2026)
  • Table 170. France Fish Vaccine, by Fish USD Million (2021-2026)
  • Table 171. Italy Fish Vaccine, by Type USD Million (2021-2026)
  • Table 172. Italy Fish Vaccine, by Administration USD Million (2021-2026)
  • Table 173. Italy Fish Vaccine, by Fish USD Million (2021-2026)
  • Table 174. United Kingdom Fish Vaccine, by Type USD Million (2021-2026)
  • Table 175. United Kingdom Fish Vaccine, by Administration USD Million (2021-2026)
  • Table 176. United Kingdom Fish Vaccine, by Fish USD Million (2021-2026)
  • Table 177. Netherlands Fish Vaccine, by Type USD Million (2021-2026)
  • Table 178. Netherlands Fish Vaccine, by Administration USD Million (2021-2026)
  • Table 179. Netherlands Fish Vaccine, by Fish USD Million (2021-2026)
  • Table 180. Rest of Europe Fish Vaccine, by Type USD Million (2021-2026)
  • Table 181. Rest of Europe Fish Vaccine, by Administration USD Million (2021-2026)
  • Table 182. Rest of Europe Fish Vaccine, by Fish USD Million (2021-2026)
  • Table 183. MEA Fish Vaccine, by Country USD Million (2021-2026)
  • Table 184. MEA Fish Vaccine, by Type USD Million (2021-2026)
  • Table 185. MEA Fish Vaccine, by Administration USD Million (2021-2026)
  • Table 186. MEA Fish Vaccine, by Fish USD Million (2021-2026)
  • Table 187. Middle East Fish Vaccine, by Type USD Million (2021-2026)
  • Table 188. Middle East Fish Vaccine, by Administration USD Million (2021-2026)
  • Table 189. Middle East Fish Vaccine, by Fish USD Million (2021-2026)
  • Table 190. Africa Fish Vaccine, by Type USD Million (2021-2026)
  • Table 191. Africa Fish Vaccine, by Administration USD Million (2021-2026)
  • Table 192. Africa Fish Vaccine, by Fish USD Million (2021-2026)
  • Table 193. North America Fish Vaccine, by Country USD Million (2021-2026)
  • Table 194. North America Fish Vaccine, by Type USD Million (2021-2026)
  • Table 195. North America Fish Vaccine, by Administration USD Million (2021-2026)
  • Table 196. North America Fish Vaccine, by Fish USD Million (2021-2026)
  • Table 197. United States Fish Vaccine, by Type USD Million (2021-2026)
  • Table 198. United States Fish Vaccine, by Administration USD Million (2021-2026)
  • Table 199. United States Fish Vaccine, by Fish USD Million (2021-2026)
  • Table 200. Canada Fish Vaccine, by Type USD Million (2021-2026)
  • Table 201. Canada Fish Vaccine, by Administration USD Million (2021-2026)
  • Table 202. Canada Fish Vaccine, by Fish USD Million (2021-2026)
  • Table 203. Mexico Fish Vaccine, by Type USD Million (2021-2026)
  • Table 204. Mexico Fish Vaccine, by Administration USD Million (2021-2026)
  • Table 205. Mexico Fish Vaccine, by Fish USD Million (2021-2026)
  • Table 206. Research Programs/Design for This Report
  • Table 207. Key Data Information from Secondary Sources
  • Table 208. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Fish Vaccine: by Type USD Million (2015-2020)
  • Figure 5. Global Fish Vaccine: by Administration USD Million (2015-2020)
  • Figure 6. Global Fish Vaccine: by Fish USD Million (2015-2020)
  • Figure 7. South America Fish Vaccine Share (%), by Country
  • Figure 8. Asia Pacific Fish Vaccine Share (%), by Country
  • Figure 9. Europe Fish Vaccine Share (%), by Country
  • Figure 10. MEA Fish Vaccine Share (%), by Country
  • Figure 11. North America Fish Vaccine Share (%), by Country
  • Figure 12. Global Fish Vaccine share by Players 2020 (%)
  • Figure 13. Global Fish Vaccine share by Players (Top 3) 2020(%)
  • Figure 14. Global Fish Vaccine share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. AquaTactics Fish Health (United States) Revenue, Net Income and Gross profit
  • Figure 17. AquaTactics Fish Health (United States) Revenue: by Geography 2020
  • Figure 18. Hipra (India) Revenue, Net Income and Gross profit
  • Figure 19. Hipra (India) Revenue: by Geography 2020
  • Figure 20. Ictyogroup (France) Revenue, Net Income and Gross profit
  • Figure 21. Ictyogroup (France) Revenue: by Geography 2020
  • Figure 22. Intervet International B.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 23. Intervet International B.V. (Netherlands) Revenue: by Geography 2020
  • Figure 24. Microsynbiotix (Ireland) Revenue, Net Income and Gross profit
  • Figure 25. Microsynbiotix (Ireland) Revenue: by Geography 2020
  • Figure 26. Nisseiken Co., Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 27. Nisseiken Co., Ltd. (Japan) Revenue: by Geography 2020
  • Figure 28. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. Pfizer Inc. (United States) Revenue: by Geography 2020
  • Figure 30. Kyoritsuseiyaku Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 31. Kyoritsuseiyaku Corporation (Japan) Revenue: by Geography 2020
  • Figure 32. Tecnovax S.A. (Argentina) Revenue, Net Income and Gross profit
  • Figure 33. Tecnovax S.A. (Argentina) Revenue: by Geography 2020
  • Figure 34. Global Fish Vaccine: by Type USD Million (2021-2026)
  • Figure 35. Global Fish Vaccine: by Administration USD Million (2021-2026)
  • Figure 36. Global Fish Vaccine: by Fish USD Million (2021-2026)
  • Figure 37. South America Fish Vaccine Share (%), by Country
  • Figure 38. Asia Pacific Fish Vaccine Share (%), by Country
  • Figure 39. Europe Fish Vaccine Share (%), by Country
  • Figure 40. MEA Fish Vaccine Share (%), by Country
  • Figure 41. North America Fish Vaccine Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • AquaTactics Fish Health (United States)
  • Hipra (India)
  • Ictyogroup (France)
  • Intervet International B.V. (Netherlands)
  • Microsynbiotix (Ireland)
  • Nisseiken Co., Ltd. (Japan)
  • Pfizer Inc. (United States)
  • Kyoritsuseiyaku Corporation (Japan)
  • Tecnovax S.A. (Argentina)
Additional players considered in the study are as follows:
Veterquimica SA (Chile) , Zoetis Inc. (United States) , Merck KGaA (Germany) , Seppic (France)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation